DADOX
Active not recruiting
100 enrolled
TARA
Recruiting
1,000 enrolled
DAROL
Active not recruiting
805 enrolled
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Recruiting
202 enrolled
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Recruiting
600 enrolled
TraveraRTGx
Completed
72 enrolled
ArtemisPRO
Active not recruiting
504 enrolled
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Recruiting
500 enrolled
RE-ENGAGE
Active not recruiting
700 enrolled
Nova-sTAR
Recruiting
150 enrolled
OBSAPA
Recruiting
270 enrolled
Double-DARE
Recruiting
1,400 enrolled
OPTYX
Active not recruiting
999 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
Bladder EpiCheck Product Development Study
Recruiting
1,000 enrolled
ROAD
Active not recruiting
1,600 enrolled
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
Recruiting
2,000 enrolled
AVENANCE
Completed
596 enrolled 43 charts
ENAiBLE
Recruiting
500 enrolled
CABOCARE
Active not recruiting
224 enrolled
REPLICA
Active not recruiting
150 enrolled
DP-04
Recruiting
100 enrolled
PSMAreal
Recruiting
170 enrolled
PULSE
Not yet recruiting
753 enrolled
HAYATE
Recruiting
100 enrolled
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Completed
1,247 enrolled
ORI-EGI-03
Recruiting
450 enrolled
PERSIST
Enrolling by invitation
178 enrolled
PROSTest_STRAT
Not yet recruiting
1,500 enrolled
VAPOR-LTR
Not yet recruiting
2,500 enrolled
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Completed
6,448 enrolled
ADONIS
Completed
554 enrolled
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Completed
494 enrolled
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Completed
2,731 enrolled 14 charts
Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Recruiting
300 enrolled
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Active not recruiting
360 enrolled
RIVERS
Recruiting
600 enrolled
CONCORD
Recruiting
400 enrolled
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Recruiting
300 enrolled
ABLE-41
Terminated
202 enrolled
23146
Not yet recruiting
500 enrolled
BASECAMP-1
Recruiting
200 enrolled
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Not yet recruiting
3,000 enrolled
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
Active not recruiting
60 enrolled
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Completed
1,083 enrolled 29 charts
PRISME
Completed
831 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
IMreal
Active not recruiting
2,756 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled